Kaminsky A, Flórez WM, Piquero MJ, Herane MI, Diez MJC, Raimondo N, Bagatin E, Steiner D, Zegpi E, Rivera M, Madrigal F, Guerra A, del Ojo D, Adame G, Arias I, Ferro L, Gómez M, Moreno J, Cantilo L, Maciel R, Sandoval B, del Solar M, Giansante E, Pérez AR

Language: Spanish
References: 15
Page: 6-10
PDF size: 427.26 Kb.

ABSTRACT

The Grupo Ibero-Latinoamericano de Estudio de la Rosácea (GILER) (Ibero-Latin American Group for the Study of Rosacea), a member of the Acne, Rosacea and Related Conditions Chapter, of the Colegio Ibero-Latinoamericano of Dermatology (CILAD), announced recently the outcome of its deliberations on the classification of rosacea and its therapy. In this consensus, the outcome of the discussions held by the Ibero-Latin American Group for the Study of Rosacea (GILER-CILAD) about the classification and treatment of rosacea, is presented. A classification that includes classical subtypes is proposed. The included in this classification are: child rosacea and rosacea extrafacial as special forms and as a variant, the granulomatous form. A diagram is presented as a therapeutic guide, which is based on international experience and that of the members of the group. Drugs and procedures that do not have enough evidence, are excluded.

REFERENCES

1. Vemuri RC, Gundamaraju R, Sekaran SD, Manikam R. Major pathophysiological correlations of rosacea: a complete clinical appraisal. Int J Med Sci. 2015 May 5;12(5):387-396

2. Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013; 69 (6 Suppl 1): S27-S35.

3. Tan J, Blume-Peytavi U, Ortonne JP, Wilhelm K, Marticou L et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol. 2013; 169 (3): 555-562.

4. Two AM, Wu W, Gallo RL, Hata TR. Rosacea. Part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015; 72 (5): 749-758.

5. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002; 46 (4): 584-587.

6. Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004; 50 (6): 907-912.

7. Elewski BE, Draelos Z, Dréno B, Jansen T, Layton A, Picardo M. Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol. 2011; 25 (2): 188-200.

8. Potz-Biedermann C, Mehra T, Deuter C, Zierhut M, Schaller M. ophthalmic rosacea: case report in a child and treatment recommendations. Pediatr Dermatol. 2015; 32 (4): 522-525.

9. Chamaillard M, Mortemousque B, Boralevi F, Marques da Costa C, Aitali F et al. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol. 2008; 144 (2): 167-171.

10. Bostanci O, Borelli C, Schaller M. Treatment of extrafacial rosacea with low-dose isotretinoin. Acta Derm Venereol. 2010; 90: 409-410.

11. Lee GL, Zirwas MJ. Granulomatous rosacea and periorificial dermatitis: controversies and review of management and treatment. Dermatol Clin. 2015; 33 (3): 447-455.

12. Del Rosso JQ. Management of cutaneous rosacea: emphasis on new medical therapies. Expert Opin Pharmacother. 2014;15 (14): 2029-2038.

13. Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield LF et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies. Cutis. 2014; 93 (1): 18-28.

14. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015; 72 (5): 761-770; quiz 771-772.

15. van Zuuren EJ, Fedorowicz Z. Interventions for Rosacea. JAMA. 2015; 314 (22): 2403-2404.